Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06629792 · ClinicalTrials.gov registry record · NA

A Clinical Study Evaluating the Efficacy and Tolerability of a Topical Facial Treatment For Facial Rejuvenation

A NA study, sponsored by Revision Skincare.

Completed
Registry status
NA
Development phase
32
Enrollment target

NCT06629792 is a NA study that has completed, run by Revision Skincare. The registered enrollment target is 32 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06629792, a NA study, has completed, sponsored by Revision Skincare.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target

Study Summary

This single-center clinical trial was conducted to evaluate the efficacy and tolerability of a topical facial treatment when applied by a license esthetician in clinic in a series of 3 sessions with 1 month intervals, in combination with a cleanser, moisturizer, and sunscreen over the course of 12 weeks in healthy women aged 35 to 60 with mild to moderate global facial fine lines, wrinkles, and laxity. Thirty-two (32) healthy female subjects completed the clinical study.

Interventions

  • OTHER Facial Moisturizer
  • OTHER Gentle Cleanser
  • OTHER sunscreen SPF 30

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2022-01-11
Est. Completion 2022-05-05
Phase NA

Sponsor

Revision Skincare

18 total trials

What the Registry Record Tells You About NCT06629792

The ClinicalTrials.gov registry entry for NCT06629792 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Revision Skincare, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Facial Moisturizer is the first listed.

NCT06629792 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06629792 about?

NCT06629792 is a clinical study titled "A Clinical Study Evaluating the Efficacy and Tolerability of a Topical Facial Treatment For Facial Rejuvenation". This single-center clinical trial was conducted to evaluate the efficacy and tolerability of a topical facial treatment when applied by a license esthetician in clinic in a series of 3 sessions with 1 month intervals, in combination with a cleanser, moisturizer, and sunscreen over the course of 12 w...

What is the current status of trial NCT06629792?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2022-01-11. Estimated completion is 2022-05-05.

What interventions are being tested in trial NCT06629792?

The interventions under investigation include: Facial Moisturizer (OTHER), Gentle Cleanser (OTHER), sunscreen SPF 30 (OTHER).

Who is sponsoring clinical trial NCT06629792?

This trial is sponsored by Revision Skincare, which has 18 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.